Verona Pharma plc (VRNA) Tops Q1 EPS by 8c

Verona Pharma plc (NASDAQ: VRNA) reported Q1 EPS of ($0.03), $0.08 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.

You May Also Be Interested In

• Broadcom credit risk measures rise amid AI financing deals
• Buffalo airport blames circuit fault, not shortage, for 3 flight delays
• Citi maintains buy ratings on Argentina power firms amid sector shifts